Search jobs
15-Jul-2020
Coagulation Testing Market Strategies of Key Players: CoaguSense, Inc., HemoSonics, LLC, iLine Microsystems., Instrumentation Laboratory Company, Sienco, Inc., SenGenix., Bio/Data Corporation
This Coagulation Testing Market report has been formulated by considering an ever increasing demand and the value of market research for the success of different business sectors. This market report comprises of many work areas of the Medical Devices industry. It is not only professional but also is a comprehensive which focuses on primary and secondary drivers, market share, competitor analysis, leading segments and geographical analysis. Moreover, this report is prepared with the combination of greatest industry insight, practical solutions, talent solutions and most recent technology. The Coagulation Testing Market advertising report also considers the major driving factors of the industry and the market restraints which generally causes inhibition. For In-Depth Information Get Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-coagulation-testing-market
Global coagulation testing market is expected to rise by 2026, registering a substantial CAGR of 7.95% in the forecast period of 2019-2026. Rising demand of special coagulation testing and increasing chronic diseases among consumer is the major factor for the growth of this market. Few of the major competitors currently working in the global coagulation testing market are: F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthcare Private Limited, CoaguSense, Inc., HemoSonics, LLC, iLine Microsystems., Instrumentation Laboratory Company, Sienco, Inc., SenGenix., Bio/Data Corporation, Universal Biosensors, RUSNANO Group, Coagulation Sciences LLC, Tcoag Ireland, SEKISUI MEDICAL CO., LTD, Thermo Fisher Scientific, Inc., Machaon Diagnostics, Inc., Laboratory Corporation of America Holdings, A&T Corporation., Sysmex, Universal Biosensors and others. Segmentation: Coagulation Testing Market
View Detailed Table of Content @  https://www.databridgemarketresearch.com/toc/?dbmr=global-coagulation-testing-market
Key Developments in the Market:
In June 2018, Roche announced the launch of their new self-testing device for INR or blood coagulation levels namely CoaguChek Vantus. This is specially designed for the Warfarin patients so that they can monitor their coagulation levels. This will increase the connectivity between the patients and healthcare provider and will provide easy and high quality testing
In May 2017, Stago group announced that they have acquired HemoSonics LLC. This acquisition will help the company to develop new Point-of-Care in Haemostasis testing and beyond with the assistance of the SEER technology (Sonic Estimation of Elasticity via Resonance) and QuantraTM Hemostasis Analyzer. The main aim of the acquisition is to provide better treatment to the patients
Competitive Analysis:
Global coagulation testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of coagulation testing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. Reasons to Purchase this Report
Current and future of global coagulation testing market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Coagulation Testing Market Drivers
Rising awareness about the preservative care management is another factor driving the market growth. Technological advancement and development in coagulation testing devices is major factor driving market
Increasing prevalence for disposable coagulation testing devices is driving the market
Coagulation Testing Market Restraints
Lack of skilled and trained professional is another factor restraining the market growth
Strict regulation related to coagulation device is another factor restraining the growth of this market
View Full Report @ https://www.databridgemarketresearch.com/reports/global-coagulation-testing-market
An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. Contact:

Coagulation Testing Market Strategies of Key Players: CoaguSense, Inc., HemoSonics, LLC, iLine Microsystems., Instrumentation Laboratory Company, Sienco, Inc., SenGenix., Bio/Data Corporation

10:36 EST 14 Nov 2018 | BioPortfolio Reports
Summary
SenGenix Inc SenGenix is a medical device company that discovers and develops pointofcare diagnostic tests based on fluorescently responsive sensors for delivering patient data to clinicians. The company develops specific molecular sensors for each analyte in its POCT product portfolio. It offers fluorescently responsive sensors that can be printed on a test strip and report on the presence and level of a clinical analyte. SenGenix' FRSbased strips are used to test various types of clinical analytes such as electrolytes, metabolites, proteins, drugs, and cells. The company offers its products and services across the US. SenGenix is headquartered in Raleigh, North Carolina, the US. SenGenix Inc  Medical Equipment  Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope
Financial Deals  Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year  Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type  Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region  Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector  Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals  Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description  A brief description of the company's operations. Key Employees  A list of the key executives of the company. Important Locations and Subsidiaries  A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors  A list of the key competitors of the company. Key Recent Developments  A brief on recent news about the company. Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

SenGenix Inc  Medical Equipment  Deals and Alliances Profile Report Updated 16102018 Prices from USD $250

10:34 EDT 29 Aug 2018 | BioPortfolio Reports
Summary
SenGenix Inc SenGenix is a medical device company that discovers and develops pointofcare diagnostic tests based on fluorescently responsive sensors for delivering patient data to clinicians. The company develops specific molecular sensors for each analyte in its POCT product portfolio. It offers fluorescently responsive sensors that can be printed on a test strip and report on the presence and level of a clinical analyte. SenGenix' FRSbased strips are used to test various types of clinical analytes such as electrolytes, metabolites, proteins, drugs, and cells. The company offers its products and services across the US. SenGenix is headquartered in Raleigh, North Carolina, the US. SenGenix Inc  Medical Equipment  Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope
Financial Deals  Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year  Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type  Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region  Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector  Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals  Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description  A brief description of the company's operations. Key Employees  A list of the key executives of the company. Important Locations and Subsidiaries  A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors  A list of the key competitors of the company. Key Recent Developments  A brief on recent news about the company. Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

SenGenix Inc  Medical Equipment  Deals and Alliances Profile Report Updated 16052018 Prices from USD $250

02:07 EDT 20 Aug 2018 | BioPortfolio Reports
Summary
SenGenix Inc SenGenix is a medical device company that discovers and develops pointofcare diagnostic tests based on fluorescently responsive sensors for delivering patient data to clinicians. The company develops specific molecular sensors for each analyte in its POCT product portfolio. It offers fluorescently responsive sensors that can be printed on a test strip and report on the presence and level of a clinical analyte. SenGenix' FRSbased strips are used to test various types of clinical analytes such as electrolytes, metabolites, proteins, drugs, and cells. The company offers its products and services across the US. SenGenix is headquartered in Raleigh, North Carolina, the US. SenGenix Inc  Medical Equipment  Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope
Financial Deals  Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year  Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type  Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region  Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector  Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals  Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description  A brief description of the company's operations. Key Employees  A list of the key executives of the company. Important Locations and Subsidiaries  A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors  A list of the key competitors of the company. Key Recent Developments  A brief on recent news about the company. Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

SenGenix Inc  Medical Equipment  Deals and Alliances Profile Report Updated 16072018 Prices from USD $250

19:41 EDT 31 Oct 2017 | BioPortfolio Reports
Summary
SenGenix Inc SenGenix is a medical device company that develops pointofcare diagnostic tests based on fluorescently responsive sensors for delivering patient data to clinicians. The company develops specific molecular sensors for each analyte in its POCT product portfolio. It offers fluorescently responsive sensors, which can be printed on a test strip and report on the presence and level of a clinical analyte. The company's FRSbased strips are used to test various types of clinical analytes such as metabolites, electrolytes, proteins, drugs, and cells. SenGenix is headquartered in Raleigh, North Carolina, the US. SenGenix Inc  Medical Equipment  Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope
Financial Deals  Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year  Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type  Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region  Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector  Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals  Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description  A brief description of the company's operations. Key Employees  A list of the key executives of the company. Important Locations and Subsidiaries  A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors  A list of the key competitors of the company. Key Recent Developments  A brief on recent news about the company. Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

SenGenix Inc  Medical Equipment  Deals and Alliances Profile Report Updated 26102017 Prices from USD $250

Nortel Networks

Glycotest

Exalenz Bioscience

HemoSense

Ortho Clinical Diagnostics

Johnson & Johnson

TEMS Systems

Beckman Coulter

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Medical Devices

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

Health Monitoring & Diagnostics

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Digital Health

Health IT 

Spinoff / Spinout

SenGenix is developing point-of-care diagnostic tests (POCT) based on fluorescently responsive sensors (FRS) that will deliver fast, accurate, actionable patient data at a low cost. The Company will commercialize protein-engineering technologies developed at Duke University Medical Center to create a product platform that will be designed to perform a menu of tests at the point-of-care. The product roll-out strategy over the next five years includes a stand-alone Creatinine test, and a Basic Metabolic Panel (BMP) consisting of the eight most commonly ordered tests (Glucose, BUN, Creatinine, Sodium, Potassium, Calcium, Chloride and Bicarbonate). These will provide clinicians with highly accurate results to assess patients at the location where care is required and within a time frame during which clinical decisions are most effective.

Name	Work History	Title	Status
Sandra Cummings	Nortel Networks	Chief Financial Officer	Current
Lawrence Cohen	Glycotest, Exalenz Bioscience, HemoSense, Ortho Clinical Diagnostics, Johnson & Johnson, TEMS Systems, and Beckman Coulter	Chief Executive Officer	Former

Name	Sandra Cummings	Lawrence Cohen
Work History	Nortel Networks	Glycotest, Exalenz Bioscience, HemoSense, Ortho Clinical Diagnostics, Johnson & Johnson, TEMS Systems, and Beckman Coulter
Title	Chief Financial Officer	Chief Executive Officer
Status	Current	Former

Wells Fargo Success Story

3M Success Story

Platform Overview

SenGenix

Executives

SenGenix Management Team

2 Team Members

Discover the right solution for your team